Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Maria Carozzi

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
BMC Infectious Diseases|July 22, 2010
Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based studyPaolo Giorgi Rossi, Simonetta Bisanzi, Irene Paganini, et al.
American Journal of Clinical Pathology|April 15, 2006
Prognostic significance of p53 and Ki-67 antigen expression in surgically treated non-small cell lung cancer: immunocytochemical detection with imprint cytologyCristina Maddau, Massimo Confortini, Simonetta Bisanzi, et al.
Tumori|October 29, 2002
Conventional pap smear and liquid-based cervical cytology smear: comparison from the same patientMassimo Confortini, Paolo Bulgaresi, Maria Paola Cariaggi, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 11, 2019
Smoking Cessation in the ITALUNG Lung Cancer Screening: What Does "Teachable Moment" Mean?Francesco Pistelli, Ferruccio Aquilini, Fabio Falaschi, et al.
Journal of Clinical Microbiology|June 28, 2013
Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) studyAnna Gillio-Tos, Laura De Marco, Francesca Maria Carozzi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 30, 2008
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CTAndrea Lopes Pegna, Giulia Picozzi, Mario Mascalchi, et al.
International Journal of Cancer|April 8, 2017
Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker studyFrancesca Maria Carozzi, Simonetta Bisanzi, Laura Carrozzi, et al.
Infectious Agents and Cancer|November 1, 2012
HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studiesPaolo Giorgi Rossi, Mario Sideri, Francesca Maria Carozzi, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 7, 2017
Cost analysis of colorectal cancer screening with CT colonography in ItalyPaola Mantellini, Giuseppe Lippi, Lapo Sali, et al.
The Lancet. Public Health|May 3, 2021
Cervical screening during the COVID-19 pandemic: optimising recovery strategiesAlejandra Castanon, Matejka Rebolj, Emily Annika Burger, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
BMC Infectious Diseases|July 22, 2010
Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based studyPaolo Giorgi Rossi, Simonetta Bisanzi, Irene Paganini, et al.
American Journal of Clinical Pathology|April 15, 2006
Prognostic significance of p53 and Ki-67 antigen expression in surgically treated non-small cell lung cancer: immunocytochemical detection with imprint cytologyCristina Maddau, Massimo Confortini, Simonetta Bisanzi, et al.
Tumori|October 29, 2002
Conventional pap smear and liquid-based cervical cytology smear: comparison from the same patientMassimo Confortini, Paolo Bulgaresi, Maria Paola Cariaggi, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 11, 2019
Smoking Cessation in the ITALUNG Lung Cancer Screening: What Does "Teachable Moment" Mean?Francesco Pistelli, Ferruccio Aquilini, Fabio Falaschi, et al.
Journal of Clinical Microbiology|June 28, 2013
Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) studyAnna Gillio-Tos, Laura De Marco, Francesca Maria Carozzi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 30, 2008
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CTAndrea Lopes Pegna, Giulia Picozzi, Mario Mascalchi, et al.
International Journal of Cancer|April 8, 2017
Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker studyFrancesca Maria Carozzi, Simonetta Bisanzi, Laura Carrozzi, et al.
Infectious Agents and Cancer|November 1, 2012
HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studiesPaolo Giorgi Rossi, Mario Sideri, Francesca Maria Carozzi, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 7, 2017
Cost analysis of colorectal cancer screening with CT colonography in ItalyPaola Mantellini, Giuseppe Lippi, Lapo Sali, et al.
The Lancet. Public Health|May 3, 2021
Cervical screening during the COVID-19 pandemic: optimising recovery strategiesAlejandra Castanon, Matejka Rebolj, Emily Annika Burger, et al.
Pageof 3